GSS vs NTI

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

GSS

GENETICSIG FPO [GSS]

54MEDIUM

NTI

NEUROTECH FPO [NTI]

42LOW

Score Breakdown

GSS NTI
Technical
50
79
Catalyst
65
53
Sentiment
50
50
Fundamental
59
67
Momentum
31
60
Risk Gate
50
31

Key Metrics

GSS Metric NTI
$14.5MMarket Cap$23.7M
877KAvg Volume (20d)2.7M
N/AShort InterestN/A
$0.43052-Week High$0.029
$0.05752-Week Low$0.010
-1.6%Daily Change+12.5%
$0.063Reference Price$0.018
-22.8%ROE-66.3%
-56.5%Profit Margin-54.4%

Active Signals

GSS Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (12 quarters)
●Low P/S ratio (0.7x)
●EPS estimates revised downward (-10pts)
●Near 52-week low (2% of range)

NTI Signals

●MACD momentum is picking up steam
●Trading above both moving averages — the trend is your friend here
●Volume surging at 2.9x normal while price falls — heavy selling pressure
●Just broke above 20-day resistance — a level that was capping price, now cleared
●On a tear — up 12.5% over the last 5 days
●Beating the Small Ords index — relative strength of 1.21, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Strong cash runway (9 quarters)

Ask Scout AI to compare GSS and NTI in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

GSS vs OCC →GSS vs PHX →GSS vs PKY →GSS vs RHY →HIQ vs ICR →
GSS Full Analysis → NTI Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).